Abbott Laboratories (ABT), a leading healthcare company in the Medical - Devices industry, demonstrates strong Shariah compliance through low debt levels, minimal impermissible income, and permissible core business activities in diagnostics, nutrition, and medical devices. All major financial ratios pass AAOIFI, MSCI, and S&P thresholds, with inclusion in all key Shariah indices confirming overall compliance. Minor purification is required for trace interest income, but no disqualifying business activities or controversies impact status. ESG alignment is positive, with low risk in governance and human rights. This report provides a multi-perspective analysis affirming ABT as a viable Shariah-compliant investment.